Showing results (31-40 of 261) with videos related to
Sort By:
Pageof 27
Seminars in Oncology|September 5, 1998
Triplet chemotherapy combinations with new agents: is there a rationale?P A BunnCancer Research|November 1, 1979
The T-lymphocyte as a diploid reference standard for flow cytometryS E Shackney, B W Erickson, K S SkramstadBritish Journal of Cancer|February 11, 2005
The analysis of relapse-free survival curves: implications for evaluating intensive systemic adjuvant treatment regimens for breast cancerR S Day, S E Shackney, W P PetersAnnals of Internal Medicine|July 1, 1978
Growth rate patterns of solid tumors and their relation to responsiveness to therapy: an analytical reviewS E Shackney, G W McCormack, G J CuchuralCytometry|May 1, 1986
Count-dependent filter for smoothing bivariate FCM histogramsW H Schuette, S E Shackney, G E MartiCytometry|September 1, 1995
Analytical approaches relating genetic evolutionary pathways to prognostic factorsA C Rohloff, J M Sakach, S E ShackneyPostgraduate Medicine|April 12, 2001
Selective estrogen receptor modulators. An aid in unraveling the links between estrogen and breast cancerS A Fuqua, J Russo, S E Shackney, et al.Clinical Lung Cancer|January 17, 2004
Combinations of three chemotherapeutic agents and two chemotherapeutic agents plus a targeted biologic agent in the treatment of advanced non small-cell lung cancerP A Bunn, K KellyLung Cancer (Amsterdam, Netherlands)|August 26, 1998
Is it time to reevaluate our approach to the treatment of brain metastases in patients with non-small cell lung cancer?K Kelly, P A BunnSeminars in Oncology|June 1, 1997
Systemic investigational therapies as adjuvants to surgery in patients with operable lung cancerP A Bunn, K KellyPageof 27